Status:
NOT_YET_RECRUITING
Robotic Radical Perineal Prostatectomy Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Robotic Radical Perineal Prostatectomy
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
Radical perineal prostatectomy (RPP) was the first approach utilized for the removal of the entire prostate gland for prostate cancer. In the minimally invasive surgery era, the robotic-assisted lapar...
Detailed Description
Radical perineal prostatectomy (RPP) was the first approach utilized for the removal of the entire prostate gland for prostate cancer \[1\]. It continued to be the favoured approach for radical prosta...
Eligibility Criteria
Inclusion
- Men aged between 40 - 80 years
- Localized prostate cancer without obvious lymph node or distant metastases
Exclusion
- Clinical T stage T3 or above
- Prostate size \>80 ml
- Patients with previous treatment of prostate cancer
- Patients with previous surgery on the prostate
- Patients with active urinary tract infection
- Patients with bladder pathology including bladder stone and bladder cancer
- Patients with urethral stricture
- Patients with neurogenic bladder and/or sphincter abnormalities
- Patients who fail to give informed consent
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04919057
Start Date
July 1 2025
End Date
March 31 2026
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital, Chinese University of Hong Kong
Hong Kong, Hong Kong